What are your top takeaways in Breast Cancer from ESMO 2025?  

I think I am probably with the majority of people who felt the big data in breast was around DESTINY-Breast05, DESTINY-Breast11, and ASCENT-03. It was a lot of ADC data across different lines, and I felt like, in particular, DB05 could be a big change for high-risk HER2+ disease with residual diseas...